GlaxoSmithKline will become the latest company to publish all its payments to doctors, and those payments will be capped at $150,000 a year, CEO Andrew Witty said. GSK previously opposed doctor ...

GlaxoSmithKline (NYSE:GSK) CEO Andrew Witty has been trying to plant seeds of optimism in an investor community that sees little reason for optimism in the global financial markets. The ...

Last week GlaxoSmithKline announced that its CEO, Sir Andrew Witty, would be stepping down from his post in early 2017. As outlined by the Financial Times , his tenure at GSK has been turbulent .

Glaxo SmithKline recently announced that its CEO, Andrew Witty, will be out the door as of March 31, 2017 – a development many were expecting. GSK has made headlines during Witty’s tenure, but ...

GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Andrew Witty Witty has told GSK's board that he ...

RESEARCH TRIANGLE PARK – Andrew Witty’s retirement keeps getting busier. The former chief executive officer at drug giant GlaxoSmithKline is taking over as CEO at Optum, the health services ...

GlaxoSmithKline (NYSE:GSK) Q3 2016 Earnings Conference Call October 26, 2016 9:00 AM ETExecutivesSir Andrew Witty - Chief Executive OfficerSimon Dingemans - ...

Through his work in poor countries, Andrew Witty, chief executive of GlaxoSmithKline, has positioned his company as the leader among drug makers in advancing world health issues.

Some CEOs of multinationals hold themselves aloof. Not Andrew Witty. The 46-year-old chief of GlaxoSmithKline visits African villages to see for himself the state of health care.

LONDON—Pharmaceutical giant GlaxoSmithKline PLCGSK0.79%increase; green up pointing triangle said Thursday that Andrew Witty would retire as chief executive in March 2017, after a career at the ...

LONDON (MarketWatch) -- GlaxoSmithKline said Monday that Andrew Witty will take over as chief executive of the British pharmaceutical giant next year, ending a battle between three of the company ...

GlaxoSmithKline PLC (NYSE:GSK) Q4 2015 Earnings Conference Call February 3, 2016 7:00 AM ETExecutivesAndrew Witty - CEOSimon Dingemans - CFOAnalystsGraham ...